The company said it anticipates 7 to 10 per cent sales growth within three years from prescription lenses (Rx Lenses) and value-added lenses.

Torn Pracharktam, Chief Executive Officer of Thai Optical Group Public Company Limited or TOG, said that sales and service revenue for 2018 were Bt1,841.57 million, being 1.92 per cent lower than the previous year. Net profits were Bt146.03 million with 7.62 per cent net profit margin, or 20.40 per cent decline from 2017 due to decreased of sales, increased of selling and administrative.

The Company reorganised its management structure by the appointment of four senior management positions namely Chief Commercial Officer, Chief Operating Officer , Chief Administrative Officer, and Chief Financial Officer. The new management team’s goal is to help advance business management potential and to create competitive advantages supporting the new customer base expansion, which focuses on the United States and the European Union markets.

The company appointed four senior management positions as follows;

Lindsay Brown as Chief Commercial Officer (CCO), who oversees sales, marketing and business development globally. Prior to joining TOG, Brown was General Manager EMEA at Transitions Optical and General Manager Global Key Accounts & Sales Director EMEA at Hoya Vision Care.

​Chaiwat Chittikun as Chief Operating Officer, who oversees manufacturing and operations including supply chain management. Chittikun held several senior management positions at Hoya Lens Thailand in various areas including manufacturing, engineering, and research & development.

Jirasuda Sumpaotong as Chief Financial Officer, who oversees accounting and finance. Sumpaotong has strong expertise in accounting and finance in various manufacturing industries. Prior to joining TOG, she was Vice President of Account & Finance at Lam Soon (Thailand) Public Company Limited.

Amolrat Pracharktam as Chief Administrative Officer, who oversees customer service, human resources, procurement, corporate affairs, sustainability development and subsidiaries/affiliates. Previously, Pracharktam has in-depth experience in the optical industry in business development, sales and marketing, and was Vice President of Supply Chain Management before being appointed as CAO.

The company outlined sales and marketing strategies by enhancing customer service excellence, ease of doing business with partners, quick response and a wide range of product portfolio offering. These will enable the company to gain competitive advantages in the global market, in addition to price competitiveness, new product offerings “Zenith” – progressive lens with the superlative patented technology “Zenith” and “Bluloc” – 95 per cent blue light reduction lens which is based on en-masse light absorption technology. The new offerings are anticipated to attract to new customers in the European and US regions as the products are high-value and high-margin, and are currently in the strong upward trend in these markets.

The company is considering the expansion plan of RX Automation Phase 2 in the second quarter of this year in order to support the volume of prescription lens orders which are expected to continuing increase from the customers in Australia and New Zealand.